A phase II clinical trial of toripalimab combined with neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma (NEOCRTEC1901)
Key Points
Key points are not available for this paper at this time.
Abstract
National Natural Science Foundation of China.
Like
Bookmark
Share
View Full Paper
Like
Bookmark
Share
View Full Paper
A phase II clinical trial of toripalimab combined with neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma (NEOCRTEC1901) | Synapse